Tourmaline Bio, Inc.

Biotechnology • Healthcare • New York, NY, United States • TRML (NMS)

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York. Tourmaline Bio, Inc. operates as a subsidiary of Novartis AG.

646 481 9832 27 West 24th Street, New York, NY 10010, United States

Stock Performance (90 Days)

Data through Oct 30, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Novartis completes acquisition of Tourmaline Bio - Novartis

Novartis • Oct 28

Tourmaline Bio To Be Acquired By Novartis; Was TRML Stock In Your Investment Portfolio? - RTTNews

RTTNews • Sep 9

Novartis Acquiring Tourmaline Bio for Cardiovascular Disease Treatment Pacibekitug - PharmExec.com

PharmExec.com • Sep 9

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio - BioPharma Dive

BioPharma Dive • Sep 9

Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened - Stocktwits

Stocktwits • Sep 9

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Tourmaline Bio, Inc. had layoffs?

No layoff events have been recorded for Tourmaline Bio, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Tourmaline Bio, Inc. have?

Tourmaline Bio, Inc. has approximately 76 employees.

What industry is Tourmaline Bio, Inc. in?

Tourmaline Bio, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Tourmaline Bio, Inc. a publicly traded company?

Yes, Tourmaline Bio, Inc. is publicly traded under the ticker symbol TRML on the NMS. The company has a market capitalization of approximately $1.23 billion.

Where is Tourmaline Bio, Inc. headquartered?

Tourmaline Bio, Inc. is headquartered in New York, NY, United States at 27 West 24th Street, New York, NY 10010, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.